Medical Cannabis Program and Adult-Use Cannabis Sales Launched by White Earth Nation
With Minnesota’s recent cannabis legalization, White Earth Nation, gets involved in the cannabis industry through their medical cannabis program and implementation of adult-use sales.
In Mahnomen, Minnesota, Waabigwan Mashkiki, a Native American cannabis manufacturing plant owned by White Earth Nation, opened in the beginning of August 2023. It became one of the first dispensaries to legally begin to sell adult-use cannabis in the state (1).
Waabigwan Mashkiki products are produced in a $10 million state-of-the-art growing facility created by cannabis production experts. The establishment has been operating and growing cannabis for two years. Waabigwan Mashkiki has been hopeful and preparing for the day adult-use cannabis was legalized.
“Others were racing to the market to capitalize on this unique time in Minnesota history,” Alexander Oxendine, General Manager of Waabigwan Mashkiki, said (1). “We have been preparing for this day for years. Because of our location, dedication to excellence, and unique and proven growing and processing practices, our product is simply better.”
The Native American cannabis manufacturing plant is overseen by Alexander Oxendine, who is a descendent of the tribe, “who honed his craft in the leading growing centers of California and understands the quality and ‘flavor of the flower’,” according to a recent press release (1). Waabigwan Mashkiki’s bud is hand-selected by experts and then slow-grown over a nine-week time period. This is different from the usual eight-week time period followed at other growing centers. Waabigwan Mashkiki offers eight strains which have been grown to produce unique benefits.
“Our plant combines the latest science and production techniques with traditional Ojibwe practices that respect connections with all living things,” Chairman Fairbanks said (1). “The result is high-quality products that are manufactured responsibly.”
With launching medical cannabis and adult-use sales, it signifies a major milestone for White Earth Nation by helping the Tribe’s commitment in providing their people with additional healthcare options.
“Our teams have been working diligently to prepare for this launch, and we’re excited to provide a safe and controlled environment for cannabis access,” Tom Lavoy, Interim Executive Director, mentioned (1). “This endeavor aligns with our tribal sovereignty and self-determination, offering a new avenue of relief for many health conditions recognized under White Earth Nation Medicinal & Adult-Use Cannabis Codes.”
The dispensary is located near Shooting Star Casino and for further information please visit: https://waabigwan.com.
Reference
- White Earth Nation Launches Medical Cannabis Program & Adult-Use Cannabis Sales https://www.kentuckytoday.com/news/business/white-earth-nation-launches-medical-cannabis-program-adult-use-cannabis-sales/article_f932ec77-30ff-5eb5-8627-b8cf27b4c7c9.html (accessed Aug 14, 2023).
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
